We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Q&A on cGMP Process Controls Stresses Risk Assessment
Q&A on cGMP Process Controls Stresses Risk Assessment
December 30, 2011
Drugmakers befuddled by manufacturing failures, such as product contamination by microorganisms, are urged to perform risk assessments and take preventive action, the FDA says.